<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17880</article-id><article-id pub-id-type="doi">10.15789/2220-7619-EPO-17880</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Early phases of tuberculosis infection: immune response and host genetic control</article-title><trans-title-group xml:lang="ru"><trans-title>Ранние фазы туберкулезной инфекции: иммунный ответ и генетический контроль хозяина</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kondratieva</surname><given-names>Tatiana K.</given-names></name><name xml:lang="ru"><surname>Кондратьева</surname><given-names>Татьяна Константиновна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Biology), Leading Researcher, Laboratory of Immunogenetics, Immunology Department</p></bio><bio xml:lang="ru"><p>д.б.н., ведущий научный сотрудник лаборатории иммуногенетики отдела иммунологии</p></bio><email>tanya.kondratieva.47@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kondratieva</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Кондратьева</surname><given-names>Елена Валерьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Senior Researcher, Laboratory of Immunogenetics, Immunology Department</p></bio><bio xml:lang="ru"><p>к.б.н., старший научный сотрудник лаборатории иммуногенетики отдела иммунологии</p></bio><email>alyonakondratyeva74@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Apt</surname><given-names>Alexander S.</given-names></name><name xml:lang="ru"><surname>Апт</surname><given-names>Александр Соломонович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Biology), Professor, Head of the Laboratory of Immunogenetics, Immunology Department</p></bio><bio xml:lang="ru"><p>д.б.н., профессор, зав. лабораторией иммуногенетики отдела иммунологии</p></bio><email>alexapt0151@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Central TB Research Institute</institution></aff><aff><institution xml:lang="ru">ФГБНУ Центральный научно-исследовательский институт туберкулеза</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-04-07" publication-format="electronic"><day>07</day><month>04</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2025-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2025</year></pub-date><volume>15</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>431</fpage><lpage>445</lpage><history><date date-type="received" iso-8601-date="2025-03-03"><day>03</day><month>03</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-03-25"><day>25</day><month>03</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Kondratieva T.K., Kondratieva E.V., Apt A.S.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Кондратьева Т.К., Кондратьева Е.В., Апт А.С.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Kondratieva T.K., Kondratieva E.V., Apt A.S.</copyright-holder><copyright-holder xml:lang="ru">Кондратьева Т.К., Кондратьева Е.В., Апт А.С.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/17880">https://iimmun.ru/iimm/article/view/17880</self-uri><abstract xml:lang="en"><p>Tuberculosis (TB), primarily pulmonary TB, continues to pose a serious threat to public health, despite intensive studies investigating related pathogenesis, as well as development and testing of novel anti-TB drugs and vaccines. One of the reasons for such a slow progress in establishing effective TB spreading control as well as improving TB prophylaxis and treatment is recognized to be due to substantial shortage of our understanding mechanisms on immune response to and genetic control of the infection, as well as key defects interfering with ability of the host to combat progressive disease. Primarily, it is accounted for by the gaps in our knowledge on early phases of infection, because clinicians virtually never experience them in real-world practice, whilst the majority of existing animal models fail to adequately mimic the events occurring in human TB-infected lung. In this review, we briefly outline some unresolved issues related to TB immunity and genetics, specifically focusing at the first month of infection. Herein, we describe interactions between mycobacteria and diverse phagocyte types in the lung tissue as well as the consequences of mycobacterial phagocytosis by alveolar and interstitial macrophages, neutrophils, eosinophils and dendritic cells. Next, the issues concerning tuberculous granuloma classification and relevant functional diversity as well as difference in immunologist and pathologist viewpoint on nature of primary tuberculous lesion are discussed. Finally, the sequence of innate and adaptive immune reactions against mycobacteria, as well as T-cell — neutrophil interplay during TB course gains special attention. Based on personal studies assessing immune response dynamics and expression of immune activation/exhaustion markers on CD4+ T-cells in MHC II allele-specific TB-infected mice we discuss key phenotypes between genetically susceptible and relatively resistant animals.</p></abstract><trans-abstract xml:lang="ru"><p>Туберкулез (ТБ), прежде всего легочный, продолжает оставаться серьезной проблемой для здравоохранения, несмотря на интенсивные исследования патогенеза болезни, разработку и проверку новых лекарств и попытки создать новые вакцины против ТБ. Одной из причин столь медленного прогресса в решении задачи эффективного контроля за распространением этой инфекции и повышения эффективности ее профилактики и лечения признается недостаток фундаментальных знаний о механизмах иммунного ответа на инфекцию, генетического контроля этого ответа и ключевых дефектах, не позволяющих зараженному хозяину справится с прогрессированием болезни. В первую очередь, недостаток наших знаний касается ранних фаз инфекции, поскольку в обычной клинической практике врачи практически с ними не встречаются, а многие существующие экспериментальные модели ТБ на животных не вполне адекватно отражают события, происходящие в зараженных M. tuberculosis легких у человека. В этом обзоре мы кратко рассматриваем некоторые нерешенные проблемы иммунологии и генетики туберкулезной инфекции со специфическим акцентом на первый месяц развития инфекции. Описывается взаимодействие микобактерий с разными типами фагоцитов в легочной ткани и последствия захвата микобактерий альвеолярными и интерстициальными макрофагами, нейтрофилами, эозинофилами и дендритными клетками. Обсуждаются вопросы классификации туберкулезных гранулем, их функциональное разнообразие различия во взглядах на природу первичных очагов туберкулезной инфекции иммунологов и патологов. В заключительном разделе обзора особое внимание уделено последовательности включения в иммунный ответ против микобактерий реакций врожденного и адаптивного иммунитета, а также регуляции взаимодействия между нейтрофилами и Т-лимфоцитами при туберкулезе. На основании собственных данных о динамике развития иммунного ответа и экспрессии на Т-клетках CD4+ маркеров активации и ингибирования ответа при экспериментальном туберкулезе у мышей, отличающихся по аллелям MHC II, обсуждаются ключевые различия между генетически чувствительными и резистентными к инфекции животными.</p></trans-abstract><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>immune cells</kwd><kwd>granuloma</kwd><kwd>genetic control</kwd><kwd>infection dynamics</kwd><kwd>immune exhaustion</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>туберкулез</kwd><kwd>иммунные клетки</kwd><kwd>гранулема</kwd><kwd>генетический контроль</kwd><kwd>динамика инфекции</kwd><kwd>иммунное истощение</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Российский научный фонд</institution></institution-wrap><institution-wrap><institution xml:lang="en">Russian Science Foundation</institution></institution-wrap></funding-source><award-id>23-14-00030</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Линге И.А., Апт А.С. Нейтрофилы: неоднозначная роль в патогенезе туберкулеза // Инфекция и иммунитет. 2021. Т. 11, № 5. C. 809–819. [Linge I.A., Apt A.S. A controversial role of neutrophils in tuberculosis infection pathogenesis. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2021, vol. 11, no. 5, pp. 809–819. (In Russ.)] doi: 10.15789/2220-7619-ACR-1670</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Майоров К.Б., Григоров А.С., Кондратьева Е.В., Ажикина Е.Л., Апт А.С. Получение Mycobacterium tuberculosis после фагоцитоза нейтрофилами in vivo для генетического и функционального анализа // Вестник ЦНИИТ. 2020. Т. 2, № 2. С. 30–35. [Majorov K.B., Grigorov A.S., Kondratieva E.V., Azhikina T.L., Apt A.S. Extraction of Mycobacterium tuberculosis after in vivo phagocytosis by neutrophils for further genetic and functional analyses. Vestnik TsNIIT = CRTI Bulletin 2020, vol. 2, no. 2, pp. 30–35. (In Russ.)] doi: 10.7868/S2587667820020041</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Abu Toamih Atamni H., Nashef A., Iraqi F.A. The collaborative cross mouse model for dissecting genetic susceptibility to infectious diseases. Mamm. Genome, 2018, vol. 29, no. 7–8, pp. 471–487. doi: 10.1007/s00335-018-9768-1</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Alvarez D., Vollmann E.H., von Andrian U.H. Mechanisms and consequences of dendritic cell migration. Immunity, 2008, vol. 29, no. 3, pp. 325–342. doi: 10.1016/j.immuni.2008.08.006</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Apt A.S. Are mouse models of human mycobacterial diseases relevant? Genetics says: ‘yes!’. Immunology, 2011, vol. 134, no. 2, pp. 109–115. doi: 10.1111/j.1365-2567.2011.03472.x</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Apt A.S., Logunova N.N., Kondratieva T.K. Host genetics in susceptibility to and severity of mycobacterial diseases. Tuberculosis (Edinb.), 2017, vol. 106, no. 1, pp. 1–8. doi: 10.1016/j.tube.2017.05.004</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Apt A., Kramnik I. Man and mouse TB: contradictions and solutions. Tuberculosis (Edinb.), 2009, vol. 89, no. 3, pp. 195–198. doi: 10.1016/j.tube.2009.02.002</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Balasubramanian V., Wiegeshaus E.H., Taylor B.T., Smith D.W. Pathogenesis of tuberculosis: pathway to apical localization. Tuber. Lung Dis., 1994, vol. 75, no. 3, pp. 168–178. doi: 10.1016/0962-8479(94)90002-7</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Basaraba R.J., Hunter R.L. Pathology of tuberculosis: How the pathology of human tuberculosis informs and directs animal models. Microbiol. Spectr., 2017, vol. 5: 5. doi: 10.1128/microbiolspec.TBTB2-0029-2016</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bermudez L.E., Goodman J. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun., 1996, vol. 64, no. 4, pp. 1400–1406. doi: 10.1128/iai.64.4.1400-1406.1996</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bermudez L.E., Sangari F.J., Kolonoski P., Petrofsky M., Goodman J. The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport withinmononuclear phagocytes and invasion of alveolar epithelial cells. Infect. Immun., 2002, vol. 70, no. 1, pp. 140–146. doi: 10.1128/IAI.70.1.140-146.2002</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Bhattacharya J., Westphalen K. Macrophage-epithelial interactions in pulmonary alveoli. Semin. Immunopathol., 2016, vol. 38, no. 4, pp. 461–469. doi: 10.1007/s00281-016-0569-x</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Blum J.S., Wearsch P.A., Cresswell P. Pathways of antigen processing. Annu. Rev. Immunol., 2013, vol. 31, pp. 443–473. doi: 10.1146/annurev-immunol-032712-095910</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Bohrer A.C., Castro E., Hu Z., Queiroz A.T. L., Tocheny C.E., Assmann M., Sakai S., Nelson C., Baker P.J., Ma H., Wang L., Zilu W., du Bruyn E., Riou C., Kauffman K.D.; Tuberculosis Imaging Program; Moore I.N., Del Nonno F., Petrone L., Goletti D., Martineau A.R., Lowe D.M., Cronan M.R., Wilkinson R.J., Barry C.E., Via L.E., Barber D.L., Klion A.D., Andrade B.B., Song Y., Wong K.W., Mayer-Barber K.D. Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice. J. Exp. Med., 2021, vol. 218: e20210469. doi: 10.1084/jem.20210469</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Bohrer A.C., Castro E., Tocheny C.E., Assmann M., Schwarz B., Bohrnsen E. Rapid Gpr183-mediated recruitment of eosinophils to the lung after mycobacterium tuberculosis infection. Cell. Rep., 2022, vol. 40: 111144. doi: 10.1016/j.celrep.2022.111144</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Borkute R.R., Woelke S., Pei G., Dorhoi A. Neutrophils in tuberculosis: cell biology, cellular networking and multitasking in host defense. Int. J. Mol. Sci., 2021, vol. 22, no. 9: 4801. doi: 10.3390/ijms22094801</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Bromley J.D., Ganchua S.K.C., Nyquist S.K., Maiello P., Chao M., Borish H.J., Rodgers M., Tomko J., Kracinovsky K., Mugahid D., Nguyen S., Wang Q.D., Rosenberg J.M., Klein E.C., Gideon H.P., Floyd-O’Sullivan R., Berger B., Scanga C.b A., Lin P.b L., Fortune S.M., Shalek A.K., Flynn J.L. CD4+ T cells re-wire granuloma cellularity and regulatory networks to promote immunomodulation following Mtb reinfection. Immunity, 2024, vol. 57, no. 10, pp. 2380–2398.e6. doi: 10.1016/j.immuni.2024.08.002</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Cadena A.M., Fortune S.M., Flynn J.L. Heterogeneity in tuberculosis. Nat. Rev. Immunol., 2017, vol. 17, no. 11, pp. 691–702. doi: 10.1038/nri.2017.69</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Cadena A.M., Flynn J.L., Fortune S.M. The importance of first impressions: early events in Mycobacterium tuberculosis infection influence outcome. mBio, 2016, vol. 7, no. 2: e00342-16. doi: 10.1128/mBio.00342-16</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Capuano S.V. 3rd, Croix D.A., Pawar S., Zinovik A., Myers A., Lin P.L., Bissel S., Fuhrman C., Klein E., Flynn J.L. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun., 2003, vol. 71, no. 10, pp. 5831–5844. doi: 10.1128/IAI.71.10.5831-5844.2003</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Carow B., Hauling T., Qian X., Kramnik I., Nilsson M., Rottenberg M.E. Spatial and temporal localization of immune transcripts defines hallmarks and diversity in the tuberculosis granuloma. Nat. Commun., 2019, vol. 10, no. 1: 1823. doi: 10.1038/s41467-019-09816-4</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Cidem A., Bradbury P., Traini D., Ong H.X. Modifying and integrating in vitro and ex vivo respiratory models for inhalation drug screening. Front. Bioeng. Biotechnol., 2020, vol. 8: 581995. doi: 10.3389/fbioe.2020.581995</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Corleisa B., Dorhoi A. Early dynamics of innate immunity during pulmonary tuberculosis. Immunol. Lett., 2020, vol. 221, pp. 56–60. doi: 10.1016/j.imlet.2020.02.010</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Correa-Macedo W., Cambri G., Schurr E. The interplay of human and Mycobacterium tuberculosis genomic variability. Front. Genet., 2019, vol. 10: 865. doi: 10.3389/fgene.2019.00865</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Dallenga T., Repnik U., Corleis B., Eich J., Reimer R., Griffiths G.W., Schaible U.E. Tuberculosis-induced necrosis of infected neutrophils promotes bacterial growth following phagocytosis by macrophages. Cell Host Microbe, 2017, vol. 22, no. 4, pp. 519–530 e3. doi: 10.1016/j.chom.2017.09.003</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Dallmann-Sauer M., Fava V.M., Malherbe S.T., MacDonald C.E., Orlova M., Kroon E.E., Cobat A., Boisson-Dupuis S., Hoal E.G., Abel L., Möller M., Casanova J.L., Walzl G., Du Plessis N., Schurr E. Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli. J. Clin. Invest., 2025: e188016. doi: 10.1172/JCI188016</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>De Waal A.M., Hiemstra P.S., Ottenhoff T.H. M., Joosten A., van der Does A M. Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis. Thorax, 2022, vol. 77, no. 4, pp. 408–416. doi: 10.1136/thoraxjnl-2021-217997</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Donald P.R., Diacon A.H., Lange C., Demers A.M., von Groote-Bidlingmaier F., Nardell E. Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878–1940. Int. J. Tuberc. Lung Dis., 2018, vol. 22 no. 9, pp. 972–982. doi: 10.5588/ijtld.18.0173</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Dyatlov A.V., Apt A.S., Linge I.A. B lymphocytes in anti-mycobacterial immune responses: Pathogenesis or protection? Tuberculosis (Edinb.), 2019, vol. 114, no. 1, pp. 1–8. doi: 10.1016/j.tube.2018.10.011</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Eruslanov E. B, Lyadova I. V, Kondratieva T.K., Majorov K.B., Scheglov I.V., Orlova M.O., Apt A.S. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect. Immun., 2005, vol. 73, no. 3, pp. 1744–1753. doi: 10.1128/IAI.73.3.1744-1753.2005</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Eum S.Y., Kong J.H., Hong M.S., Lee Y.J., Kim J.H., Hwang S.H., Cho S.N., Via L.E., Barry C.F. 3rd. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest, 2010, vol. 137, no. 1, pp. 122–128. doi: 10.1378/chest.09-0903</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Flynn J.L., Chan J. Immune cell interactions in tuberculosis. Cell, 2022, vol. 185, no. 25, pp. 4682–4702. doi: 10.1016/j.cell.2022.10.025</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Forbes J.R., Gros P. Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood, 2003, vol. 102, no. 5, pp. 1884–1892. doi: 10.1182/blood-2003-02-0425</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Gideon H.P., Hughes T.K., Tzouanas C.N., Wadsworth M.H., Tu A.A., Gierahn T.M., Peters J.M., Hopkins F.F., Wei J.-R., Kummerlowe C. Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control. Immunity, 2022, vol. 55, no. 5, pp. 827–846.e10. doi: 10.1016/j.immuni.2022.04.004</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Gill A.M. Eosinophilia in tuberculosis. BMJ, 1940, vol. 17, pp. 220–221. doi: 10.1136/bmj.2.4154.220</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Grant A.V., Sabri A., Abid A., Abderrahmani Rhorfi I., Benkirane M. , Souhi H., Naji Amrani H., Alaoui-Tahiri K., Gharbaoui Y., Lazrak F., Sentissi I., Manessouri M., Belkheiri S., Zaid S., Bouraqadi A., El Amraoui N., Hakam M., Belkadi A., Orlova M., Boland A., Deswarte C., Amar L., Bustamante J., Boisson-Dupuis S., Casanova J.L., Schurr E., El Baghdadi J., Abel L. A genome-wide association study of pulmonary tuberculosis in Morocco. Hum. Genet., 2016, vol. 135. no. 3, pp. 299–307. doi: 10.1007/s00439-016-1633-2</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Guilliams M., Lambrecht B.N., Hammad H. Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal. Immunol., 2013, vol. 6, no. 3, pp. 464–473. doi: 10.1038/mi.2013.14</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Gutierrez M.C., Brisse S., Brosch R., Fabre M., Omaïs B., Marmiesse M., Supply P., Vincent V. Ancient origin and gene mosaicism of the pro genitor of mycobacterium tuberculosis. PLoS Pathog., 2005, vol. 1, no. 1: e5. doi: 10.1371/journal.ppat.0010005</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Hashimoto D., Chow A., Noizat C., Teo P., Beasley M.B., Leboeuf M., Becker C.D., See P., Price J., Lucas D., Greter M., Mortha A., Boyer S.W., Forsberg E.C., Tanaka M., van Rooijen N., García-Sastre A., Stanley E.R., Ginhoux F., Frenette P.S, Merad M. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity, 2013, vol. 38, no. 4, pp. 792–804. doi: 10.1016/j.immuni.2013.04.004</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Hoeffel G., Chen J., Lavin Y., Low D., Almeida F.F., See P., Beaudin A.E., Lum J., Low I., Forsberg E.C., Poidinger M., Zolezzi F., Larbi A., Ng L.G., Chan J.K., Greter M., Becher B., Samokhvalov I.M., Merad M., Ginhoux F. C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity, 2015, vol. 42, no. 4, pp. 665–678. doi: 10.1016/j.immuni.2015.03.011</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Hoeffel G., Ginhoux F. Fetal monocytes and the origins of tissue-resident macrophages. Cell. Immunol., 2018, vol. 330, pp. 5–15. doi: 10.1016/j.cellimm.2018.01.001</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Huang L., Nazarova E.V., Tan S., Liu Y., Russell D.G. Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. J. Exp. Med., 2018, vol. 215, no. 4, pp. 1135–1152. doi: 10.1084/jem.20172020</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Hunter R.L. The pathogenesis of tuberculosis — The Koch phenomenon reinstated. Pathogens, 2020, vol. 9, no. 10: 813. doi: 10.3390/pathogens9100813</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Iakobachvili N., Leon-Icaza S.A., Knoops K., Sachs N., Mazères S., Simeone R., Peixoto A., Bernard C., Murris-Espin M., Mazières J., Cam K., Chalut C., Guilhot C., López-Iglesias C., Ravelli R.B., Neyrolles J., Meunier E., Lugo-Villarino G., Clevers H., Cougoule C., Peters P.J. Mycobacteria–host interactions in human bronchiolar airway organoids. Mol. Microbiol., 2022, vol. 117, no. 3, pp. 682–692. doi: 10.1111/mmi.14824</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Ji D.X., Witt K.C., Kotov D.I., Margolis S.R., Louie A., Chevée V., Chen K.J., Gaidt M.M., Dhaliwal H.S., Lee A.Y., Nishimura S.L., Zamboni D.S., Kramnik I., Portnoy D.A., Darwin K.H., Vance R.E. Role of the transcriptional regulator SP140 in resistance to bacterial infections via repression of type I interferons. Elife, 2021, vol. 10: e67290. doi: 10.7554/eLife.67290</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Kawasaki T., Ikegawa M., Kawai T. Antigen presentation in the lung. Front. Immunol., 2022, vol. 13: 860915. doi: 10.3389/fimmu.2022.860915</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Khan N., Vidyarthi A., Pahari S., Agrewala J.N. Distinct strategies employed by dendritic cells and macrophages in restricting mycobacterium tuberculosis infection: different philosophies but same desire. Int. Rev. Immunol., 2016, vol. 35, no. 5, pp. 386–398. doi: 10.3109/08830185.2015.1015718</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Klion A.D., Ackerman S.J., Bochner B.S. Contributions of eosinophils to human health and disease. Annu. Rev. Pathol., 2020, vol. 15, pp. 179–209. doi: 10.1146/annurev-pathmechdis-012419-032756</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Kondratieva E., Logunova N., Majorov K., Averbakh M., Apt A. Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to M. tuberculosis and M. avium. PLoS One, 2010, vol. 5: e10515. doi: 10.1371/journal.pone.0010515</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Kondratieva E., Majorov K., Grigorov A., Skvortsova Y., Kondratieva T., Rubakova E., Linge I., Azhikina T., Apt A. An in vivo model of separate M. tuberculosis phagocytosis by neutrophils and macrophages: gene expression profiles in the parasite and disease development in the mouse host. Int. J. Mol. Sci., 2022, vol. 23, no. 6: 2961. doi: 10.3390/ijms23062961</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Kramnik I. Genetic dissection of host resistance to Mycobacterium tuberculosis: the sst1 locus and the Ipr1 gene. Curr. Top. Microbiol. Immunol., 2008, vol. 321, pp. 123–148. doi: 10.1007/978-3-540-75203-5_6</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Kramnik I., Beamer G. Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies. Semi. Immunopathol., 2016, vol. 38, no. 2, pp. 221–237. doi: 10.1007/s00281-015-0538-9</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Lavin Y., Mortha A., Rahman A., Merad M. Regulation of macrophage development and function in peripheral tissues. Nat. Rev. Immunol., 2015, vol. 15, no. 12, pp. 731–744. doi: 10.1038/nri3920</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Leu J.S., Chen M.L., Chang S.Y., Yu S.L., Lin C.W., Wang H., Chen W.C., Chang C.H. , Wang J.Y., Lee L.N., Yu C.J., Kramnik I., Yan B.S. SP110b сontrols host immunity and susceptibility to tuberculosis. Am. J. Respir. Crit. Care Med., 2017, vol. 195, no. 3, pp. 369–382. doi: 10.1164/rccm.201601-0103OC</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Lin P.L., Ford C.B., Coleman M.T., Myers A.J., Gawande R., Ioerger T., Sacchettini J., Fortune S.M., Flynn J.L. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat. Med., 2014, vol. 20, no. 1, pp. 75–79. doi: 10.1038/nm.3412</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Linge I., Dyatlov A., Kondratieva E., Avdienko V., Apt A., Kondratieva T. B-lymphocytes forming follicle-like structures in the lung tissue of tuberculosis-infected mice: dynamics, phenotypes and functional activity. Tuberculosis (Edinb.), 2017, vol. 102, pp. 16–23. doi: 10.1016/j.tube.2016.11.005</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Linge I., Kondratieva T., Apt A. B-cell follicles in tuberculous lung: active defenders or modest bystanders? Immunology, 2023, vol. 169, no. 4, pp. 515–518. doi: 10.1111/imm.13657</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Logunova N.N., Kapina M.A., Dyatlov A.V., Kondratieva T.K., Rubakova E.V., Majorov K.B., Kondratieva E.V., Linge I.A., Apt A.S. Polygenic TB control and the sequence of innate/adaptive immune responses to infection: MHC-II alleles determine the size of the S100A8/9-producing neutrophil population. Immunology, 2024, vol. 173, no. 2, pp. 381–393. doi: 10.1111/imm.13836</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Logunova N.N., Kapina M.A., Kondratieva E.V., Apt A.S. The H2-A Class II molecule α/β-chain cis-mismatch severely affects cell surface expression, selection of conventional CD4+ T cells and protection against TB infection. Front. Immunol., 2023, vol. 14: 1183614. doi: 10.3389/fimmu.2023.1183614. doi: 10.3389/fimmu.2023.1183614</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Logunova N.N., Kriukova V.V., Shelyakin P.V., Egorov E.S., Pereverzeva A., Bozhanova N.G., Shugay M., Shcherbinin D.S., Pogorelyy M.V., Merzlyak E.M., Zubov V.N., Meiler J., Chudakov D.M., Apt A.S., Britanova O.V. MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naïve CD4+ T cells. Proc. Natl Acad. Sci. USA, 2020, vol. 117, no. 24, pp. 13659–13669. doi: 10.1073/pnas.2003170117</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Logunova N., Kapina M., Kriukova V., Britanova O., Majorov K., Linge I., Apt A. Susceptibility to and severity of tuberculosis infection in mice depends upon MHC-II-determined level of activation-inhibition balance in CD4 T-cells. Immunology, 2025. (In press)</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Logunova N., Korotetskaya M., Polshakov V., Apt A. The QTL within the H2 complex involved in the control of tuberculosis infection in mice is the classical class II H2-Ab1 gene. PLoS Genet., 2015, vol. 11: e1005672. doi: 10.1371/journal.pgen.1005672</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Lowe D.M., Redford P.S., Wilkinson R J., O’Garra A., Martineau A.R. Neutrophils in tuberculosis: friend or foe? Trends Immunol., 2012, vol. 33. no. 1, pp. 14–25. doi: 10.1016/j.it.2011.10.003</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Lyu J., Narum D.E., Baldwin S.L., Larsen S.E., Bai X., Griffith D.E., Dartois V., Naidoo T., Steyn A.J. C., Coler R.N., Chan E.D. Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. Front. Immunol., 2024, vol. 15: 1427559. doi: 10.3389/fimmu.2024.1427559</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Majorov K.B., Lyadova I.V., Kondratieva T.K., Eruslanov E.B., Rubakova E.I., Orlova M.O., Mischenko V.V., Apt A.S. Different innate ability of I/St and A/Sn mice to combat virulent Mycobacterium tuberculosis: phenotypes expressed in lung and extrapulmonary macrophages. Infect. Immun., 2003, vol. 71, no. 2, pp. 697–707. doi: 10.1128/IAI.71.2.697-707.2003</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>McCaffrey E.F., Donato M., Keren L., Chen Z., Delmastro A., Fitzpatrick M.B., Gupta S., Greenwald N.F., Baranski A. , Graf W., Kumar R., Bosse M., Fullaway C.C., Ramdial P.K., Forgó E., Jojic V., Van Valen D., Mehra S., Khader S.A., Bendall S.C., van de Rijn M., Kalman D., Kaushal D., Hunter R.L., Banaei N., Steyn A.J., Khatri P., Angelo M. The immunoregulatory landscape of human tuberculosis granulomas. Nat. Immunol., 2022, vol. 23, no. 2, pp. 318–329. doi: 10.1038/s41590-021-01121-x</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>McDonough K.A., Kress Y. Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect. Immun., 1995, vol. 63, no. 12, pp. 4802–4811. doi: 10.1128/iai.63.12.4802-4811.1995</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Meade R.K., Smith C.M. Immunological roads diverged: mapping tuberculosis outcomes in mice. Trends Microbiol., 2025, vol. 33, no. 1, pp. 15–33. doi: 10.1016/j.tim.2024.06.007</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Mihret A. The role of dendritic cells in mycobacterium tuberculosis infection. Virulence 2012, vol. 3, no. 7, pp. 654–659. doi: 10.4161/viru.22586</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Mischenko V.V., Kapina M.A., Eruslanov E.B., Kondratieva E.V., Lyadova I.V., Young D.B., Apt A.S. Mycobacterial dissemination and cellular responses after 1-lobe restricted tuberculosis infection of genetically susceptible and resistant mice. J. Infect. Dis., 2004, vol. 190, no. 12, pp. 2137–2145. doi: 10.1086/425909</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Muefong C.N., Sutherland J.S. Neutrophils in tuberculosis-associated inflammation and lung pathology. Front. Immunol., 2020, vol. 11: 962. doi: 10.3389/fimmu.2020.00962</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Nandi B., Behar S.M. Regulation of neutrophils by interferon γ limits lung inflammation during tuberculosis infection. J. Exp. Med., 2011, vol. 208, no. 11, pp. 2251–2262. doi: 10.1084/jem.20110919</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Nardell E.A. Transmission and institutional infection control of tuberculosis. Cold Spring Harb. Perspect. Med., 2015, vol. 6, no. 2: a018192. doi: 10.1101/cshperspect.a018192</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Niazi M.K., Dhulekar N., Schmidt D., Major S., Cooper R., Abeijon C., Gatti D.M., Kramnik I., Yener B., Gurcan M., Beamer G. Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice. Dis. Model. Mech., 2015, vol. 8, no. 9, pp. 1141–1153. doi: 10.1242/dmm.020867</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>O’Grady F., Riley R.L. Experimental airborne tuberculosis. Adv. Tuberc. Rev., 1963, vol. 12, pp. 150–190.</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Padilla-Carlin D.J., McMurray D.N., Hickey A.J. The guinea pig as a model of infectious diseases. Comp. Med., 2008, vol. 58, no. 4, pp. 324–340.</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Pai S., Muruganandah V., Kupz A. What lies beneath the airway mucosal barrier? Throwing the spotlight on antigen-presenting cell function in the lower respiratory tract. Clin. Transl. Immunology, 2020, vol. 9, no. 7: e1158. doi: 10.1002/cti2.1158</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Peters М., Peters K., Bufens A. Regulation of lung immunity by dendritic cells: Implications for asthma, chronic obstructive pulmonary disease and infectious disease. Innate Immun., 2019, vol. 25, no. 6, pp. 326–336. doi: 10.1177/1753425918821732</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Pisu D. Huang L., Narang V., Theriault M., Lê-Bury G., Lee B., Lakudzala A.E., Mzinza D.T., Mhango D.V., Mitini-Nkhoma S.C., Jambo K.C., Singhal A., Mwandumba H.C., Russell D.G. Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung. J. Exp. Med., 2021, vol. 218, no. 9: e20210615. doi: 10.1084/jem.20210615</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Pisu D., Johnston L., Mattila J.T., Russell D.G. The frequency of CD38+ alveolar macrophages correlates with early control of M. tuberculosis in the murine lung. Nature Communications 2024, vol. 15, no. 1: 8522. doi: 10.1038/s41467-024-52846-w</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Plumlee C.R., Barrett H.W., Shao D.E., Lien K.A., Cross L.M. , Cohen S.B., Edlefsen P.T., Urdahl K.B. Assessing vaccine-mediated protection in an ultra-low dose Mycobacterium tuberculosis murine model. PLoS Pathog., 2023, vol. 19, no. 11: e1011825. doi: 10.1371/journal.ppat.1011825</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Plumlee C.R., Duffy F.J., Gern B.H., Delahaye J.L., Cohen S.B., Stoltzfus C.R., Rustad T.R., Hansen S.G., Axthelm M.K., Picker L.J., Aitchison J.D., Sherman D.R., Ganusov V.V., Gerner M.Y., Zak D.E., Urdahl K.B. Ultra-low dose aerosol infection of mice with Mycobacterium tuberculosis more closely models human tuberculosis. Cell Host Microbe, 2021, vol. 29, no. 1, pp. 68–82.e5. doi: 10.1016/j.chom.2020.10.003</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Reiley W.W., Calayag M.D., Wittmer S.T., Huntington J.L., Pearl J.E., Fountain J.J., Martino C.A., Roberts A.D., Cooper A.M., Winslow G.M., Woodland D.L. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc. Natl Acad. Sci. USA, 2008, vol. 105, no. 31, pp. 10961–10966. doi: 10.1073/pnas.0801496105</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Reuschl A.-K., Edwards M.R., Parker R., Connell D.W., Hoang L., Halliday A., Jarvis H., Siddiqui N., Wright C., Bremang S., Newton S.M., Beverley P., Shattock R.J., Kon O.M., Lalvani A. Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airways. PLoS Pathog., 2017, vol. 13: e1006577–26. doi: 10.1371/journal.ppat.1006577</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Riley R.L., Mills C.C., Nyka W., Weinstock N., Storey P.B., Sultan L.U., Riley M.C., Wells W.F. Aerial dissemination of pulmonary tuberculosis. A two year study of contagion in a tuberculosis ward. Am. J. Hyg., 1959, vol. 70, pp. 185–196.</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Russell D.G., Simwela N.V., Mattila J.T., Flynn J., Mwandumba H.C. , Pisu D. How macrophage heterogeneity affects tuberculosis disease and therapy. Nat. Rev. Immunol., 2025. doi: 10.1038/s41577-024-01124-3</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Ryndak M.B., Chandra D., Laal S. Understanding dissemination of Mycobacterium tuberculosis from the lungs during primary infection. J. Med. Microbiol., 2016, vol. 65, no. 5, pp. 362–369. doi: 10.1099/jmm.0.000238</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Saini D., Hopkins G.W., Seay S.A., Chen C.J., Perley C.C., Click E.M., Frothingham R. Ultra-low dose of Mycobacterium tuberculosis aerosol creates partial infection in mice. Tuberculosis (Edinb.), 2012, vol. 92, no. 2, pp. 160–165. doi: 10.1016/j.tube.2011.11.007</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Sankar P., Mishra B.B. Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis. Front. Immunol., 2023, vol. 14: 1260859. doi: 10.3389/fimmu.2023.1260859</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Sawyer A.J., Patrick E., Edwards J., Wilmott J.S., Fielder T., Yang Q., Barber D.L., Ernst J.D., Britton W.J., Palendira U., Chen X., Feng C.G. Spatial mapping reveals granuloma diversity and histopathological superstructure in human tuberculosis. J. Exp. Med., 2023, vol. 220, no. 6: e20221392. doi: 10.1084/jem.20221392</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Sutherland J.S., Jeffries D.J., Donkor S., Walther B., Hill P.C., Adetifa I.M., Adegbola R.A., Ota M.O. High Granulocyte/Lymphocyte ratio and paucity of NKT cells defines tb disease in a tb-endemic setting. Tuberculosis (Edinb.), 2009, vol. 89, no. 6, pp. 398–404. doi: 10.1016/j.tube.2009.07.004</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Tian T., Woodworth J., Skold M., Behar S.M. In vivo depletion of Cd11c+ cells delays the Cd4+ t-cell response to Мycobacterium tuberculosis and exacerbates the outcome of infection. J. Immunol., 2005, vol. 175, no. 5, pp. 3268–3272. doi: 10.4049/jimmunol.175.5.3268</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Ulrichs T., Kosmiadi G.A., Trusov V., Jörg S., Pradl L.,Titukhina M., Mishenko V., Gushina N., Kaufmann S.H. E. Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defense in the lung. J. Pathol., 2004, vol. 204, no. 2, pp. 217–228. doi: 10.1002/path.1628</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Urdahl K.B. Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis. Semin. Immunol., 2014, vol. 26, no. 6, pp. 578–587. doi: 10.1016/j.smim.2014.10.003</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Verissimo L., Castro F.C., Muñoz-Mérida A., Almeida T., Gaigher A., Neves F., Flajnik M.F., Ohta Y. An ancestral Major Histocompatibility Complex organization in cartilaginous fish: reconstructing MHC origin and evolution. Mol. Biol. Evol., 2023, vol. 40, no. 12: msad262. doi: 10.1093/molbev/msa</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>Via L.E., Lin P.L., Ray S.M., Carrillo J., Allen S.S., Eum S.Y. , Taylor K., Klein E., Manjunatha U., Gonzales J., Lee E.G., Park S.K., Raleigh J.A., Cho S.N., McMurray D.N. , Flynn J. L ., Barry C.E. 3rd. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun., 2008, vol. 76, no. 6, pp. 2333–2340. doi: 10.1128/IAI.01515-07</mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation>Vidal S., Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell, 1993, vol. 73, no. 3, pp. 469–485. doi: 10.1016/0092-8674(93)90135-d</mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation>Wells W.F., Ratcliffe H.L., Grumb C. On the mechanics of droplet nuclei infection: quantitative experimental air-borne tuberculosis in rabbits. Am. J. Hyg., 1948, vol. 47, no. 1, pp. 11–28. doi: 10.1093/oxfordjournals.aje.a119179</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation>Williams A., Orme I.M. Animal models of tuberculosis: an overview. Microbiol. Spectr., 2016, vol. 4: 4. doi: 10.1128/microbiolspec.TBTB2-0004-2015</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation>Woo Y.D., Jeong D., Chung D.H. Development and functions of alveolar macrophages. Mol. Cells, 2021, vol. 44, no. 5, pp. 292–330. doi: 10.14348/molcells.2021.0058</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation>Yeremeev V., Linge I., Kondratieva T., Apt A. Neutrophils exacerbate tuberculosis infection in genetically susceptible mice. Tuberculosis (Edinb.), 2015, vol. 95, no. 4, pp. 447–451. doi: 10.1016/j.tube.2015.03.007</mixed-citation></ref></ref-list></back></article>
